Literature DB >> 27267000

Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues.

Mariagrazia Roselli1, Alessia Carocci2, Roberta Budriesi3, Matteo Micucci3, Maddalena Toma1, Lorenzo Di Cesare Mannelli4, Angelo Lovece1, Alessia Catalano1, Maria Maddalena Cavalluzzi1, Claudio Bruno1, Annalisa De Palma5, Marialessandra Contino1, Maria Grazia Perrone1, Nicola Antonio Colabufo1, Alberto Chiarini3, Carlo Franchini1, Carla Ghelardini4, Solomon Habtemariam6, Giovanni Lentini1.   

Abstract

Four mexiletine analogues have been tested for their antiarrhythmic, inotropic, and chronotropic effects on isolated guinea pig heart tissues and to assess calcium antagonist activity, in comparison with the parent compound mexiletine. All analogues showed from moderate to high antiarrhythmic activity. In particular, three of them (1b,c,e) were more active and potent than the reference drug, while exhibiting only modest or no negative inotropic and chronotropic effects and vasorelaxant activity, thus showing high selectivity of action. All compounds showed no cytotoxicity and 1b,c,d did not impair motor coordination. All in, these new analogues exhibit an interesting cardiovascular profile and deserve further investigation.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antiarrhythmics; Inotropism; MW-assisted synthesis; Mexiletine; P-glycoprotein

Mesh:

Substances:

Year:  2016        PMID: 27267000     DOI: 10.1016/j.ejmech.2016.05.046

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels.

Authors:  Gualtiero Milani; Maria Maddalena Cavalluzzi; Concetta Altamura; Antonella Santoro; Mariagrazia Perrone; Marilena Muraglia; Nicola Antonio Colabufo; Filomena Corbo; Elisabetta Casalino; Carlo Franchini; Isabella Pisano; Jean-François Desaphy; Antonio Carrieri; Alessia Carocci; Giovanni Lentini
Journal:  ChemMedChem       Date:  2021-10-05       Impact factor: 3.540

2.  Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2.

Authors:  Christina Mousele; Emma Matthews; Robert D S Pitceathly; Michael G Hanna; Susan MacDonald; Konstantinos Savvatis; Aisling Carr; Christopher Turner
Journal:  Neurol Clin Pract       Date:  2021-10

3.  Densely Functionalized 2-Methylideneazetidines: Evaluation as Antibacterials.

Authors:  Giovanni Petrillo; Cinzia Tavani; Lara Bianchi; Alice Benzi; Maria Maddalena Cavalluzzi; Lara Salvagno; Laura Quintieri; Annalisa De Palma; Leonardo Caputo; Antonio Rosato; Giovanni Lentini
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

Review 4.  Systems Medicine as an Emerging Tool for Cardiovascular Genetics.

Authors:  Tina Haase; Daniela Börnigen; Christian Müller; Tanja Zeller
Journal:  Front Cardiovasc Med       Date:  2016-08-30

5.  Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential.

Authors:  Michela De Bellis; Francesca Sanarica; Alessia Carocci; Giovanni Lentini; Sabata Pierno; Jean-François Rolland; Diana Conte Camerino; Annamaria De Luca
Journal:  Front Pharmacol       Date:  2018-01-12       Impact factor: 5.810

Review 6.  Fragment-based drug discovery: opportunities for organic synthesis.

Authors:  Jeffrey D St Denis; Richard J Hall; Christopher W Murray; Tom D Heightman; David C Rees
Journal:  RSC Med Chem       Date:  2020-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.